Search Results - "Zierz, S"
-
1
Physical fatigability and muscle pain in patients with Hashimoto thyroiditis
Published in Journal of neurology (01-07-2021)“…Introduction Hashimoto thyroiditis (HT) may lead to muscle weakness due to hypothyroid dysfunction. However, clinical experience treating patients with HT…”
Get full text
Journal Article -
2
Manifesting heterozygotes in carnitine palmitoyltransferase (CPT) II deficiency
Published in Neuromuscular disorders : NMD (01-10-2016)Get full text
Journal Article -
3
S45-3 Diagnostic value of muscle biopsy versus molecular genetics in myopathies
Published in Clinical neurophysiology (2010)Get full text
Journal Article -
4
The significance of pathological spontaneous activity in various myopathies
Published in Clinical neurophysiology (01-07-2014)“…Highlights • High frequency discharges (i.e., myotonic discharges and complex repetitive discharges) occur frequently in non-myotonic dystrophies as Pompe…”
Get full text
Journal Article -
5
EP 89. Experimental provocation of “ice-cream headache” by ice cubes and ice water
Published in Clinical neurophysiology (01-09-2016)“…Introduction Ice-cream headache, now called “Headache attributed to ingestion or inhalation of cold stimulus” (HICS), is characterized by a short-lasting…”
Get full text
Journal Article -
6
EP 42. Smooth muscle involvement in Glycogenosis Type II: Thalamus hemorrhage, increased blood flow and dolichoectasia in a late-onset Pompe patient
Published in Clinical neurophysiology (01-09-2016)“…Introduction Pompe disease (Glycogenosis Type II) is a rare autosomal-recessive disorder caused by mutations in the GAA gene encoding for the lysosomal α…”
Get full text
Journal Article -
7
Treatment of adult idiopathic inflammatory myopathies with conventional immunosuppressive drugs: Results of a retrospective study
Published in Zeitschrift für Rheumatologie (01-03-2019)“…Objectives To gain information about the efficacy of immunosuppressive drugs as first-, second-, and third-line treatment of idiopathic inflammatory myopathies…”
Get full text
Journal Article -
8
C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis
Published in Journal of neurology (01-11-2012)“…Mutations in C19orf12 have been recently identified as the molecular genetic cause of a subtype of neurodegeneration with brain iron accumulation (NBIA). Given…”
Get full text
Journal Article -
9
Polyglucosan myopathy and functional characterization of a novel GYG1 mutation
Published in Acta neurologica Scandinavica (01-03-2018)“…Objectives Disorders of glycogen metabolism include rare hereditary muscle glycogen storage diseases with polyglucosan, which are characterized by storage of…”
Get full text
Journal Article -
10
Use of complementary and alternative medicine in patients suffering from primary headache disorders
Published in Cephalalgia (01-10-2009)“…Complementary and alternative medicine (CAM) is increasingly common in the treatment of primary headache disorders despite lack of evidence for efficacy in…”
Get more information
Journal Article -
11
T.P.29
Published in Neuromuscular disorders : NMD (01-10-2014)“…McArdle’s disease is characterized by deficiency of enzyme myophosphorylase that disrupts the mechanism of glycogen breakdown in skeletal muscle. In McArdle…”
Get full text
Journal Article -
12
Melas associated with mutations in the POLG1 gene
Published in Neurology (15-05-2007)Get full text
Journal Article -
13
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study
Published in Journal of Neural Transmission (01-05-2005)“…Increasing evidence has suggested that oxidative stress may be involved in the pathogenesis of amyotrophic lateral sclerosis (ALS). The antioxidant vitamin E…”
Get full text
Journal Article -
14
P39. Assigning pathogenicity to three novel mt-tRNA mutations associated with different mitochondrial disease presentations
Published in Clinical neurophysiology (01-08-2015)“…Mitochondrial transfer RNA (mt-tRNA) mutations are the commonest mitochondrial (mtDNA) mutations associated with human disease. Assigning pathogenicity to…”
Get full text
Journal Article -
15
Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations
Published in Journal of neurology (01-06-2011)“…Autosomal-dominant centronuclear myopathy (CNM) due to mutations in the dynamin 2 gene ( DNM2 ) is a rare congenital myopathy histopathologically characterized…”
Get full text
Journal Article -
16
P.17.14 Myohistological mitochondrial changes in patients with mtDNA singular deletions, multiple deletions and A3243G point mutation
Published in Neuromuscular disorders : NMD (01-10-2013)“…Chronic progredient external opthalmoplegia (CPEO) and the MELAS syndrome are the most common disorders that are associated with mitochondrial changes. CPEO is…”
Get full text
Journal Article -
17
Sensory ataxic neuropathy due to a novel C10Orf2 mutation with probable germline mosaicism
Published in Neurology (25-01-2005)“…The authors describe siblings with progressive external ophthalmoplegia (PEO) due to a novel heterozygous A to G transition at nucleotide 955 of C10Orf2…”
Get full text
Journal Article -
18
Unusual manifestations in two cases of necrotizing myopathy associated with SRP-antibodies
Published in Clinical neurology and neurosurgery (01-09-2012)“…Abstract Anti-SRP (signal recognition particle) positive necrotizing myopathy is commonly not associated with neoplasms. We demonstrate two histologically…”
Get full text
Journal Article -
19
Cerebrovascular reactivity is impaired in patients with cardiac failure
Published in European heart journal (01-03-2000)“…Aims We undertook this study to evaluate potential changes in cerebral vasoreactivity in patients with cardiac failure and their consequent dependence upon…”
Get full text
Journal Article -
20
Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2)
Published in Neurology (25-07-2006)“…The authors performed neuropsychological testing in 21 patients with myotonic dystrophy type 1 (DM1) and 21 with type 2 (DM2) and healthy controls. They…”
Get full text
Journal Article